PL376796A1 - Sposób wytwarzania inhibitorów fosfodiesterazy-4 - Google Patents

Sposób wytwarzania inhibitorów fosfodiesterazy-4

Info

Publication number
PL376796A1
PL376796A1 PL376796A PL37679603A PL376796A1 PL 376796 A1 PL376796 A1 PL 376796A1 PL 376796 A PL376796 A PL 376796A PL 37679603 A PL37679603 A PL 37679603A PL 376796 A1 PL376796 A1 PL 376796A1
Authority
PL
Poland
Prior art keywords
phosphodiesterase
preparing inhibitors
inhibitors
preparing
Prior art date
Application number
PL376796A
Other languages
English (en)
Inventor
Jennifer Albaneze-Walker
Jerry Anthony Murry
Arash Soheili
Shawn A. Springfield
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of PL376796A1 publication Critical patent/PL376796A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL376796A 2002-11-22 2003-11-18 Sposób wytwarzania inhibitorów fosfodiesterazy-4 PL376796A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42831502P 2002-11-22 2002-11-22
US47265503P 2003-05-22 2003-05-22

Publications (1)

Publication Number Publication Date
PL376796A1 true PL376796A1 (pl) 2006-01-09

Family

ID=32397111

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376796A PL376796A1 (pl) 2002-11-22 2003-11-18 Sposób wytwarzania inhibitorów fosfodiesterazy-4

Country Status (14)

Country Link
US (1) US7312334B2 (pl)
EP (1) EP1565466A2 (pl)
JP (1) JP2006513271A (pl)
KR (1) KR20050085107A (pl)
AR (1) AR042194A1 (pl)
AU (1) AU2003291050A1 (pl)
BR (1) BR0316464A (pl)
CA (1) CA2506656A1 (pl)
HR (1) HRP20050450A2 (pl)
MX (1) MXPA05005405A (pl)
NZ (1) NZ539646A (pl)
PL (1) PL376796A1 (pl)
RU (1) RU2323938C2 (pl)
WO (1) WO2004048377A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105084A1 (en) * 2004-04-26 2005-11-10 Merck Frosst Canada Ltd. Alternative forms of the phosphodiesterase-4 inhibitor n-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide
CA2661850A1 (en) * 2006-09-01 2008-03-06 Kyorin Pharmaceutical Co., Ltd. Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same
MX2009010946A (es) * 2007-04-11 2009-10-29 Alcon Res Ltd Uso de un inhibidor del factor de necrosis tumoral alfa mas una antihistamina para tratar rinitis alergica y conjuntivitis alergica.
KR20120091037A (ko) * 2009-10-01 2012-08-17 알콘 리서치, 리미티드 올로파타딘 조성물 및 그의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757508A (fr) 1969-10-15 1971-04-14 Rieter Ag Maschf Procede pour la production d'un faisceau de fibres continu regulier et dispositif pour l'execution du procede
AR208414A1 (es) * 1974-11-07 1976-12-27 Rhone Poulenc Ind Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
AU2002257459B2 (en) * 2001-05-24 2006-12-14 Merck Frosst Canada Ltd 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
JO2311B1 (en) * 2001-08-29 2005-09-12 ميرك فروست كندا ليمتد Alkyl inhibitors Ariel phosphodiesterase-4

Also Published As

Publication number Publication date
KR20050085107A (ko) 2005-08-29
MXPA05005405A (es) 2005-08-03
US20060019981A1 (en) 2006-01-26
HRP20050450A2 (en) 2006-02-28
CA2506656A1 (en) 2004-06-10
WO2004048377A2 (en) 2004-06-10
AR042194A1 (es) 2005-06-15
JP2006513271A (ja) 2006-04-20
AU2003291050A1 (en) 2004-06-18
US7312334B2 (en) 2007-12-25
BR0316464A (pt) 2005-10-11
EP1565466A2 (en) 2005-08-24
RU2323938C2 (ru) 2008-05-10
RU2005119645A (ru) 2006-01-20
NZ539646A (en) 2008-03-28
WO2004048377A3 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
GB0325192D0 (en) Method of use
GB0322989D0 (en) Method of deriving data
EP1549316A4 (en) HAMMER OF TFGbeta
GB0308731D0 (en) Method of radiotherapy
EP1603476A4 (en) PROCESS FOR REMOVING TATTOO
ZA200403741B (en) Method of timberland management
SG131944A1 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
SI1578695T1 (sl) Postopek za odstranitev biofilma
EP1577280A4 (en) DEUTERATION PROCESS
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
GB0302572D0 (en) Method of treatment
GB0306309D0 (en) Method of treatment
EP1488046A4 (en) CONSTRUCTION METHODS
EP1512783A4 (en) KNITTING METHOD
PL376796A1 (pl) Sposób wytwarzania inhibitorów fosfodiesterazy-4
GB0208897D0 (en) New method of treatment
AU2003276825A8 (en) Method of immunotherapy
AP1845A (en) Method of demal protection
GB0213198D0 (en) Method of treatment
AU2003299623A8 (en) Method of making mercaptoalkylalkyldialkoxysilanes
GB0222736D0 (en) Method of authentication
GB0207091D0 (en) Method of treatment
GB0423692D0 (en) Method of communicating
PL351938A1 (en) Method of obtaining fructisiltransferase
GEU20041064U (en) Method for production of Matsoni

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)